Sven de Vos
APLA Health(US)University of California, Los Angeles(US)Ronald Reagan UCLA Medical Center(US)Los Angeles Medical Center(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Viral-associated cancers and disorders
Most-Cited Works
- → Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia(2014)1,603 cited
- → Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma(2012)1,502 cited
- → Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma(2015)1,102 cited
- → PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma(2014)1,053 cited
- → Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia(2009)734 cited
- → Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma(2006)706 cited